XCAT

PT Kilang Pertamina Internasional selects Univation's UNIPOL™ PE Process for Two Reactor Lines in Indonesia

Retrieved on: 
Monday, November 14, 2022

HOUSTON, Nov. 14, 2022 /PRNewswire/ -- PT Kilang Pertamina Internasional ("PT-KPI") has selected Univation's UNIPOL PE Process for two reactor lines.

Key Points: 
  • HOUSTON, Nov. 14, 2022 /PRNewswire/ -- PT Kilang Pertamina Internasional ("PT-KPI") has selected Univation's UNIPOL PE Process for two reactor lines.
  • PT-KPI will access the "full-density" flexibility of their two new UNIPOL PE Process lines to produce a broad array of both HDPE and LLDPE products to satisfy growing PE demand within the Indonesian region.
  • PT-KPI has also selected Univation's advanced process control platform PREMIER APC+ 3.0 to further enhance the overall operating performance of their two UNIPOL PE Process lines.
  • PT Kilang Pertamina Internasional (PT-KPI) is the refining & petrochemical subholding company of PT Pertamina (Persero) that acts as a strategic holding company.

Red Sea National Petrochemical Company selects Univation's UNIPOL™ PE Process for Two World-Scale Reactor Lines in Egypt

Retrieved on: 
Wednesday, September 28, 2022

HOUSTON, Sept. 28, 2022 /PRNewswire/ -- The Red Sea National Petrochemical Company ("Red Sea") has selected Univation's UNIPOL PE Process for two reactor lines.

Key Points: 
  • HOUSTON, Sept. 28, 2022 /PRNewswire/ -- The Red Sea National Petrochemical Company ("Red Sea") has selected Univation's UNIPOL PE Process for two reactor lines.
  • We are very proud that Red Sea selected Univation's UNIPOL PE Process for this impressive integrated project in Egypt.
  • Red Sea will take complete advantage of the broad product flexibility of the UNIPOL PE Process by designing both plants with "full-density" capabilities providing Red Sea the ability to produce both HDPE and LLDPE products in either reactor platform.
  • Red Sea National Petrochemical Company added the following comments, "The Red Sea project is an important step for both our company and for the country of Egypt towards becoming a regional center for value-added petrochemical products.

xCAT IQ Installed at Hadassah University Hospital

Retrieved on: 
Thursday, September 1, 2022

Xoran's xCAT IQ is a truly mobile cone beam CT system for soft tissue and bone imaging.

Key Points: 
  • Xoran's xCAT IQ is a truly mobile cone beam CT system for soft tissue and bone imaging.
  • With high resolution down to 70 microns and an extremely small footprint, the xCAT IQ is uniquely suited to meet the needs of the Hadassah clinicians.
  • The implementation of xCAT IQ was largely facilitated by the efforts of Prof. Yoram Weiss, MD, Director General of the Hadassah Medical Organization.
  • Since the establishment of Hadassah's first hospital on Jerusalem's Neviim Street (Street of the Prophets) - a gift of the Rothschild family in 1918 - the Hadassah University Medical Center has expanded to include two University hospitals in Jerusalem - located on Mt.

Xoran Announces FDA 510(k) Clearance for Truly Mobile Fluoroscopy-CT TRON™

Retrieved on: 
Thursday, August 4, 2022

ANN ARBOR, Mich., Aug. 4, 2022 /PRNewswire/ -- Xoran Technologies announces that last month it received FDA 510(k) clearance for TRON a truly mobile, full-body fluoroscopy, computed tomography (CT) X-ray system.

Key Points: 
  • ANN ARBOR, Mich., Aug. 4, 2022 /PRNewswire/ -- Xoran Technologies announces that last month it received FDA 510(k) clearance for TRON a truly mobile, full-body fluoroscopy, computed tomography (CT) X-ray system.
    "
  • ... TRON scans take less than a minute, ... the system is easy-to-use, it can be further mobilized ..." CEO Misha Raki
    "When Xoran states that TRON is the 'One RING to rule them all,' we truly mean that this compact, mobile, open-bore device is poised to revolutionize global initiatives to democratize access to diagnostic imaging," says Xoran CEO Misha Rakic.
  • "Its compact size and weight make it truly nimble without any need for bulky motors and batteries," continues Rakic.
  • Since 2001, Xoran is the pioneer and medical market leader in low-dose radiation, cone beam CT systems specifically designed for the patient's point-of-care.

Red Beard Sailing Is Now The Official US Dealer For The Brand New Line Of Astus Boats

Retrieved on: 
Tuesday, July 19, 2022

Rosedale, July 19, 2022 (GLOBE NEWSWIRE) -- Red Beard Sailing is an independently owned, one-stop-shop for portable sailboats, inflatable kayaks, inflatable canoes, inflatable dinghies and sailing accessories.

Key Points: 
  • Rosedale, July 19, 2022 (GLOBE NEWSWIRE) -- Red Beard Sailing is an independently owned, one-stop-shop for portable sailboats, inflatable kayaks, inflatable canoes, inflatable dinghies and sailing accessories.
  • The boat manufacturer Astus, who has recently partnered with renowned naval architect firm VPLP to redesign their latest line of boats, has now announced that Red Beard Sailing is the official US dealer for their brand new range of Astus Boats .
  • The new line of Astus Boats offers users exceptional handling, high speed, and brilliant performance all in a small, lightweight and convenient package.
  • To find out more about Red Beard Sailing and to see their full Astus Boats selection, please visit their website at https://redbeardsailing.com/ .

Xoran Technologies Submits FDA 510(k) Application for TRON

Retrieved on: 
Thursday, June 30, 2022

ANN ARBOR, Mich., June 30, 2022 /PRNewswire/ --Xoran Technologies announced the company's recent submission of an FDA 510(k) application for TRON, an open-bore fluoroscopy computed tomography (CT) for full-body point-of-care imaging.

Key Points: 
  • ANN ARBOR, Mich., June 30, 2022 /PRNewswire/ --Xoran Technologies announced the company's recent submission of an FDA 510(k) application for TRON, an open-bore fluoroscopy computed tomography (CT) for full-body point-of-care imaging.
  • With over 20 patents, this FDA 510(k) submission builds on the company's continued research and development effortsfor lungcomputed tomography (CT)imaging.
  • Those research efforts have shown marked capability in point-of-care CT solutions for the neuro intensive care unit (NICU), the operating room, and satellite stations.
  • Since 2001, Xoran is the pioneer and medical market leader in low-dose radiation, cone beam CT systems specifically designed for the patient's point-of-care.

Xoran Technologies Starts Work on Phase 2 of Mobile Lung CT NIH Grant

Retrieved on: 
Wednesday, June 22, 2022

ANN ARBOR, Mich., June 22, 2022 /PRNewswire/ -- Today, Xoran Technologies announces they have begun work on Phase 2 of their mobile lung grant with the goal to confirm the safety and utility of a future thoracic point-of-care CT system in support of an FDA 510k submission.

Key Points: 
  • ANN ARBOR, Mich., June 22, 2022 /PRNewswire/ -- Today, Xoran Technologies announces they have begun work on Phase 2 of their mobile lung grant with the goal to confirm the safety and utility of a future thoracic point-of-care CT system in support of an FDA 510k submission.
  • In 2021, Xoran Technologies was notified of a grant award from the National Heart, Lung, and Blood Institute (NHLBI) through the National Institutes of Health (NIH) to support the company's research and development efforts for lung cone beam computed tomography (CT) imaging.
  • Earlier this year, Xoran announced they completed Phase 1 of this grant.
  • Just last month, Xoran submitted its 510k for TRON, an open-bore fluoroscopy CT for full-body point-of-care imaging.

Xoran Announces New Patent for Modular Computed Tomography System Assembly

Retrieved on: 
Wednesday, June 8, 2022

ANN ARBOR, Mich., June 8, 2022 /PRNewswire/ --Xoran Technologies has recently received a patent for a modular computed tomography (CT) system assembly.

Key Points: 
  • ANN ARBOR, Mich., June 8, 2022 /PRNewswire/ --Xoran Technologies has recently received a patent for a modular computed tomography (CT) system assembly.
  • "This revolutionary cone beam CT configuration paired with our twenty-and-counting current patents unlocks new capabilities.
  • The technology is just the beginning of a new generation of Xoran's point-of-care (POC) imaging devices," explains Misha Rakic, Xoran CEO.
  • Since 2001, Xoran has been the pioneer and medical market leader in low-dose radiation, cone beam CT systems specifically designed for the patient's point-of-care.

Xoran Technologies Completes Phase 1 for Mobile Lung CT Grant from National Heart, Lung, and Blood Institute (NHLBI)

Retrieved on: 
Friday, May 20, 2022

ANN ARBOR, Mich., May 20, 2022 /PRNewswire/ -- Today, Xoran Technologies announced they have completed Phase 1 for their NHLBI grant for mobile lung CT. "This grant allows Xoran to commercialize our future open-bore CT products quickly," explains Misha Rakic, Xoran's CEO.

Key Points: 
  • ANN ARBOR, Mich., May 20, 2022 /PRNewswire/ -- Today, Xoran Technologies announced they have completed Phase 1 for their NHLBI grant for mobile lung CT. "This grant allows Xoran to commercialize our future open-bore CT products quickly," explains Misha Rakic, Xoran's CEO.
  • Earlier this month, Xoran submitted its 510k for TRON, an open-bore fluoroscopy CT for full-body point-of-care imaging.
  • Just last year, Xoran Technologies was notified of a grant award from the National Heart, Lung, and Blood Institute (NHLBI) to support the company's research and development efforts for lung cone beam computed tomography (CBCT) imaging.
  • Leveraging its knowledge and experience in the field as pioneer and medical market leader in CBCT, Xoran has proposed an open-bore, truly mobile CT to assist in identification of lung disease.

Univation Technologies and Axens Sign Agreement to Improve Efficiency of Linear Alpha Olefins and Polyethylene Resins Production

Retrieved on: 
Tuesday, March 1, 2022

HOUSTON, March 1, 2022 /PRNewswire/ -- Axens and Univation Technologies have entered into a cooperation agreement with the purpose of developing improved capital and operating efficiencies for the production of on-purpose linear alpha olefins (LAO) including both 1-butene and 1-hexene for use in manufacturing polyethylene resins with the UNIPOL PE Process.

Key Points: 
  • HOUSTON, March 1, 2022 /PRNewswire/ -- Axens and Univation Technologies have entered into a cooperation agreement with the purpose of developing improved capital and operating efficiencies for the production of on-purpose linear alpha olefins (LAO) including both 1-butene and 1-hexene for use in manufacturing polyethylene resins with the UNIPOL PE Process.
  • Jean-Luc Nocca, Executive Vice-President at Axens, and responsible for the Commercial Business Division, stated, "We look forward to cooperating with Univation Technologies and bring additional values to our customers by developing synergies."
  • Univation is also the world's leading manufacturer and supplier of conventional and advanced polyethylene polymerization catalysts designed specifically for the UNIPOL PE Process.
  • UNIPOL is a trademark of The Dow Chemical Company ("Dow") or an affiliated company of Dow, licensed for use to Univation Technologies.